{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:13:50Z","timestamp":1792664030899,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T00:00:00Z","timestamp":1464652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00105-016-3800-8","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T09:26:04Z","timestamp":1464686764000},"page":"422-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pathogenese der Psoriasis vulgaris","Pathogenesis of psoriasis"],"prefix":"10.1007","volume":"67","author":[{"given":"K.","family":"Sch\u00e4kel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P.","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ghoreschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,31]]},"reference":[{"key":"3800_CR1","first-page":"S2","volume":"33","author":"W Alwan","year":"2015","unstructured":"Alwan W, Nestle FO (2015) Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine. Clin Exp Rheumatol 33:S2\u2013S6","journal-title":"Clin Exp Rheumatol"},{"key":"3800_CR2","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1084\/jem.20151093","volume":"212","author":"A Arakawa","year":"2015","unstructured":"Arakawa A, Siewert K, St\u00f6hr J et\u00a0al (2015) Melanocyte antigen triggers autoimmunity in human psoriasis. J\u00a0Exp Med 212:2203\u20132212","journal-title":"J Exp Med"},{"key":"3800_CR3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI1476","volume":"101","author":"K Asadullah","year":"1998","unstructured":"Asadullah K, Sterry W, Stephanek K et al (1998) IL\u201110 is a key cytokine in psoriasis. Proof of principle by IL\u201110 therapy: a new therapeutic approach. J\u00a0Clin Invest 101:783\u2013794","journal-title":"J Clin Invest"},{"key":"3800_CR4","doi-asserted-by":"crossref","first-page":"628289","DOI":"10.1155\/2014\/628289","volume":"2014","author":"A Batycka-Baran","year":"2014","unstructured":"Batycka-Baran A, Maj J, Wolf R et al (2014) The new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasis. J Immunol Res 2014:628289","journal-title":"J Immunol Res"},{"key":"3800_CR5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","volume":"8","author":"E Bettelli","year":"2007","unstructured":"Bettelli E, Oukka M, Kuchroo VK (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345\u2013350","journal-title":"Nat Immunol"},{"key":"3800_CR6","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nm0797-702c","volume":"3","author":"WH Boehncke","year":"1997","unstructured":"Boehncke WH (1997) Graft persistence in animal models of psoriasis. Nat Med 3:702\u2013703","journal-title":"Nat Med"},{"key":"3800_CR7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP (2015) Psoriasis. Lancet 386:983\u2013994","journal-title":"Lancet"},{"key":"3800_CR8","first-page":"946","volume":"7","author":"WH Boehncke","year":"2009","unstructured":"Boehncke WH, Sterry W (2009) Psoriasis \u2013 a systemic inflammatory disorder: clinic, pathogenesis and therapeutic perspectives. J\u00a0Dtsch Dermatol Ges 7:946\u2013952","journal-title":"J Dtsch Dermatol Ges"},{"key":"3800_CR9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00714.x","volume":"226","author":"K Boniface","year":"2008","unstructured":"Boniface K, Blom B, Liu YJ et al (2008) From interleukin-23 to T\u2011helper 17 cells: human T\u2011helper cell differentiation revisited. Immunol Rev 226:132\u2013146","journal-title":"Immunol Rev"},{"key":"3800_CR10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4049\/jimmunol.156.2.794","volume":"156","author":"M Breban","year":"1996","unstructured":"Breban M, Fernandez-Sueiro JL, Richardson JA et al (1996) T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol 156:794\u2013803","journal-title":"J Immunol"},{"key":"3800_CR11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1523-1747.1998.00213.x","volume":"110","author":"AD Burden","year":"1998","unstructured":"Burden AD, Javed S, Bailey M et\u00a0al (1998) Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p. J\u00a0Invest Dermatol 110:958\u2013960","journal-title":"J Invest Dermatol"},{"issue":"5","key":"3800_CR12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1189\/jlb.1213633","volume":"95","author":"X Chen","year":"2014","unstructured":"Chen X, Oppenheim JJ (2014) Th17 cells and Tregs: unlikely allies. J\u00a0Leukoc Biol 95(5):723\u2013731","journal-title":"J Leukoc Biol"},{"key":"3800_CR13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","volume":"372","author":"FS Collins","year":"2015","unstructured":"Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372:793\u2013795","journal-title":"N Engl J Med"},{"key":"3800_CR14","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","volume":"129","author":"A Cesare Di","year":"2009","unstructured":"Cesare A Di, Meglio P Di, Nestle FO (2009) The IL\u201123\/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339\u20131350","journal-title":"J Invest Dermatol"},{"key":"3800_CR15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.immuni.2011.12.003","volume":"35","author":"P Meglio Di","year":"2011","unstructured":"Meglio P Di, Perera GK, Nestle FO (2011) The multitasking organ: recent insights into skin immune function. Immunity 35:857\u2013869","journal-title":"Immunity"},{"key":"3800_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/exd.12300","volume":"23","author":"G Drozdenko","year":"2014","unstructured":"Drozdenko G, Heine G, Worm M (2014) Oral vitamin D increases the frequencies of CD38+ human B cells and ameliorates IL\u201117-producing T cells. Exp Dermatol 23:107\u2013112","journal-title":"Exp Dermatol"},{"key":"3800_CR17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM200107263450403","volume":"345","author":"CN Ellis","year":"2001","unstructured":"Ellis CN, Krueger GG, Alefacept Clinical Study Group (2001) Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 345:248\u2013255","journal-title":"N Engl J Med"},{"key":"3800_CR18","doi-asserted-by":"crossref","first-page":"15258","DOI":"10.1074\/jbc.272.24.15258","volume":"272","author":"M Frohm","year":"1997","unstructured":"Frohm M, Agerberth B, Ahangari G et al (1997) The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 272:15258\u201315263","journal-title":"J Biol Chem"},{"key":"3800_CR19","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/jid.2010.165","volume":"130","author":"J Fuentes-Duculan","year":"2010","unstructured":"Fuentes-Duculan J, Suarez-Farinas M, Zaba LC et al (2010) A subpopulation of CD163-positive macrophages is classically activated in psoriasis. J\u00a0Invest Dermatol 130:2412\u20132422","journal-title":"J Invest Dermatol"},{"key":"3800_CR20","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20090480","volume":"206","author":"D Ganguly","year":"2009","unstructured":"Ganguly D, Chamilos G, Lande R et al (2009) Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J\u00a0Exp Med 206:1983\u20131994","journal-title":"J Exp Med"},{"key":"3800_CR21","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/archderm.1990.01670350139033","volume":"126","author":"M Gardembas-Pain","year":"1990","unstructured":"Gardembas-Pain M, Ifrah N, Foussard C et al (1990) Psoriasis after allogeneic bone marrow transplantation. Arch Dermatol 126:1523","journal-title":"Arch Dermatol"},{"key":"3800_CR22","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1084\/jem.20100977","volume":"208","author":"K Ghoreschi","year":"2011","unstructured":"Ghoreschi K, Br\u00fcck J, Kellerer C et\u00a0al (2011) Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. J\u00a0Exp Med 208:2291\u20132303","journal-title":"J Exp Med"},{"key":"3800_CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/exd.12265","volume":"23","author":"K Ghoreschi","year":"2014","unstructured":"Ghoreschi K, Gadina M (2014) Jakpot! New small molecules in autoimmune and inflammatory diseases. Exp Dermatol 23:7\u201311","journal-title":"Exp Dermatol"},{"key":"3800_CR24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","volume":"228","author":"K Ghoreschi","year":"2009","unstructured":"Ghoreschi K, Laurence A, O\u2019Shea JJ (2009) Janus kinases in immune cell signaling. Immunol Rev 228:273\u2013287","journal-title":"Immunol Rev"},{"key":"3800_CR25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ni.1701","volume":"10","author":"K Ghoreschi","year":"2009","unstructured":"Ghoreschi K, Laurence A, O\u2019Shea JJ (2009) Selectivity and therapeutic inhibition of kinases: to be or not to be? Nat Immunol 10:356\u2013360","journal-title":"Nat Immunol"},{"key":"3800_CR26","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi K, Laurence A, Yang XP et al (2010) Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467:967\u2013971","journal-title":"Nature"},{"key":"3800_CR27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nm804","volume":"9","author":"K Ghoreschi","year":"2003","unstructured":"Ghoreschi K, Thomas P, Breit S et al (2003) Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 9:40\u201346","journal-title":"Nat Med"},{"key":"3800_CR28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.clindermatol.2007.08.012","volume":"25","author":"K Ghoreschi","year":"2007","unstructured":"Ghoreschi K, Weigert C, R\u00f6cken M (2007) Immunopathogenesis and role of T cells in psoriasis. Clin Dermatol 25:574\u2013580","journal-title":"Clin Dermatol"},{"key":"3800_CR29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1501646","volume":"373","author":"KB Gordon","year":"2015","unstructured":"Gordon KB, Duffin KC, Bissonnette R et\u00a0al (2015) A\u00a0phase 2 trial of Guselkumab versus Adalimumab for plaque psoriasis. N Engl J Med 373:136\u2013144","journal-title":"N Engl J Med"},{"key":"3800_CR30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(15)60125-8","volume":"386","author":"CE Griffiths","year":"2015","unstructured":"Griffiths CE, Reich K, Lebwohl M et al (2015) Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet 386:541\u2013551","journal-title":"Lancet"},{"key":"3800_CR31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa0810652","volume":"362","author":"CE Griffiths","year":"2010","unstructured":"Griffiths CE, Strober BE, Kerkhof P Van De et al (2010) Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med 362:118\u2013128","journal-title":"N Engl J Med"},{"key":"3800_CR32","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1073\/pnas.1416922112","volume":"112","author":"E Guenova","year":"2015","unstructured":"Guenova E, Skabytska Y, Hoetzenecker W et al (2015) IL\u20114 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL\u201123 in antigen-presenting cells. Proc Natl Acad Sci USA 112:2163\u20132168","journal-title":"Proc Natl Acad Sci USA"},{"key":"3800_CR33","doi-asserted-by":"crossref","first-page":"225re1","DOI":"10.1126\/scitranslmed.3008089","volume":"6","author":"J Guinea-Viniegra","year":"2014","unstructured":"Guinea-Viniegra J, Jimenez M, Schonthaler HB et al (2014) Targeting miR-21 to treat psoriasis. Sci Transl Med 6:225re1","journal-title":"Sci Transl Med"},{"issue":"3","key":"3800_CR34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jaci.2010.12.009","volume":"127","author":"A H\u00e4nsel","year":"2011","unstructured":"H\u00e4nsel A, G\u00fcnther C, Ingwersen J et al (2011) Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17\/TH1\u202fT-cell responses. J\u00a0Allergy Clin Immunol 127(3):787\u2013794.e9","journal-title":"J Allergy Clin Immunol"},{"key":"3800_CR35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","volume":"64","author":"JL Harden","year":"2015","unstructured":"Harden JL, Krueger JG, Bowcock AM (2015) The immunogenetics of Psoriasis: A comprehensive review. J\u00a0Autoimmun 64:66\u201373","journal-title":"J Autoimmun"},{"key":"3800_CR36","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/jid.2011.486","volume":"132","author":"Z Hegyi","year":"2012","unstructured":"Hegyi Z, Zwicker S, Bureik D et al (2012) Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 \u201calarmins\u201d psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis. J Invest Dermatol 132:1416\u20131424","journal-title":"J Invest Dermatol"},{"key":"3800_CR37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/exd.12892","volume":"25","author":"AC Hund","year":"2016","unstructured":"Hund AC, Lockmann A, Sch\u00f6n MP (2016) Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-kappaB inhibitors - implications for dose-sparing combination therapies. Exp Dermatol 25:124\u2013130","journal-title":"Exp Dermatol"},{"key":"3800_CR38","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir H, Kreymborg K, Ifergan I et al (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13:1173\u20131175","journal-title":"Nat Med"},{"key":"3800_CR39","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/jid.2013.526","volume":"134","author":"RR Keijsers","year":"2014","unstructured":"Keijsers RR, Hendriks AG, Van Erp PE et al (2014) In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORgammat and IL\u201117. J\u00a0Invest Dermatol 134:1276\u20131284","journal-title":"J Invest Dermatol"},{"key":"3800_CR40","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/exd.12487","volume":"23","author":"RR Keijsers","year":"2014","unstructured":"Keijsers RR, Joosten I, Van Erp PE et al (2014) Cellular sources of IL\u201117 in psoriasis: a paradigm shift? Exp Dermatol 23:799\u2013803","journal-title":"Exp Dermatol"},{"key":"3800_CR41","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.4049\/jimmunol.181.7.4733","volume":"181","author":"I Kryczek","year":"2008","unstructured":"Kryczek I, Bruce AT, Gudjonsson JE et al (2008) Induction of IL\u201117+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 181:4733\u20134741","journal-title":"J Immunol"},{"key":"3800_CR42","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/ncomms6621","volume":"5","author":"R Lande","year":"2014","unstructured":"Lande R, Botti E, Jandus C et al (2014) The antimicrobial peptide LL37 is a T\u2011cell autoantigen in psoriasis. Nat Commun 5:5621","journal-title":"Nat Commun"},{"key":"3800_CR43","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","volume":"449","author":"R Lande","year":"2007","unstructured":"Lande R, Gregorio J, Facchinetti V et al (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449:564\u2013569","journal-title":"Nature"},{"key":"3800_CR44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","volume":"371","author":"RG Langley","year":"2014","unstructured":"Langley RG, Elewski BE, Lebwohl M et\u00a0al (2014) Secukinumab in plaque psoriasis \u2013 results of two phase 3 trials. N Engl J Med 371:326\u2013338","journal-title":"N Engl J Med"},{"key":"3800_CR45","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa1503824","volume":"373","author":"M Lebwohl","year":"2015","unstructured":"Lebwohl M, Strober B, Menter A et\u00a0al (2015) Phase 3 studies comparing Brodalumab with Ustekinumab in psoriasis. N Engl J Med 373:1318\u20131328","journal-title":"N Engl J Med"},{"key":"3800_CR46","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbrc.2012.05.162","volume":"423","author":"Y Lee","year":"2012","unstructured":"Lee Y, Jang S, Min JK et\u00a0al (2012) S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin. Biochem Biophys Res Commun 423:647\u2013653","journal-title":"Biochem Biophys Res Commun"},{"key":"3800_CR47","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","volume":"187","author":"AM Lin","year":"2011","unstructured":"Lin AM, Rubin CJ, Khandpur R et al (2011) Mast cells and neutrophils release IL\u201117 through extracellular trap formation in psoriasis. J Immunol 187:490\u2013500","journal-title":"J Immunol"},{"key":"3800_CR48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/jid.2013.315","volume":"134","author":"VN Lorenz","year":"2014","unstructured":"Lorenz VN, Sch\u00f6n MP, Seitz CS (2014) c\u2011Rel downregulation affects cell cycle progression of human keratinocytes. J Invest Dermatol 134:415\u2013422","journal-title":"J Invest Dermatol"},{"key":"3800_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.02.003","author":"VN Lorenz","year":"2016","unstructured":"Lorenz VN, Sch\u00f6n MP, Seitz CS (2016) c\u2011Rel in epidermal homeostasis: a spotlight on c\u2011Rel in cell cycle regulation. J Invest Dermatol. doi:10.1016\/j.jid.2016.02.003","journal-title":"J Invest Dermatol"},{"key":"3800_CR50","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm.2150","volume":"16","author":"K Loser","year":"2010","unstructured":"Loser K, Vogl T, Voskort M et al (2010) The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat Med 16:713\u2013717","journal-title":"Nat Med"},{"key":"3800_CR51","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","volume":"128","author":"MA Lowes","year":"2008","unstructured":"Lowes MA, Kikuchi T, Fuentes-Duculan J et al (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17\u202fT cells. J Invest Dermatol 128:1207\u20131211","journal-title":"J Invest Dermatol"},{"key":"3800_CR52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes MA, Suarez-Farinas M, Krueger JG (2014) Immunology of psoriasis. Annu Rev Immunol 32:227\u2013255","journal-title":"Annu Rev Immunol"},{"key":"3800_CR53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaad.2013.12.036","volume":"71","author":"CW Lynde","year":"2014","unstructured":"Lynde CW, Poulin Y, Vender R et\u00a0al (2014) Interleukin 17\u202fA: toward a new understanding of psoriasis pathogenesis. J\u00a0Am Acad Dermatol 71:141\u2013150","journal-title":"J Am Acad Dermatol"},{"key":"3800_CR54","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ni.1698","volume":"10","author":"MJ McGeachy","year":"2009","unstructured":"McGeachy MJ, Chen Y, Tato CM et al (2009) The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 10:314\u2013324","journal-title":"Nat Immunol"},{"key":"3800_CR55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/jid.2011.259","volume":"132","author":"S Morizane","year":"2012","unstructured":"Morizane S, Yamasaki K, M\u00fchleisen B et al (2012) Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. J Invest Dermatol 132:135\u2013143","journal-title":"J Invest Dermatol"},{"key":"3800_CR56","first-page":"555","volume":"301","author":"W Mueller","year":"1979","unstructured":"Mueller W, Herrmann B (1979) Cyclosporin A for psoriasis. N Engl J Med 301:555","journal-title":"N Engl J Med"},{"key":"3800_CR57","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1600-0625.2010.01134.x","volume":"19","author":"P Muhr","year":"2010","unstructured":"Muhr P, Renne J, Schaefer V et al (2010) Primary human keratinocytes efficiently induce IL\u20111-dependent IL\u201117 in CCR6+ T cells. Exp Dermatol 19:1105\u20131107","journal-title":"Exp Dermatol"},{"key":"3800_CR58","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1600-0625.2011.01325.x","volume":"20","author":"M Murakami","year":"2011","unstructured":"Murakami M, Hagforsen E, Morhenn V et al (2011) Patients with palmoplantar pustulosis have increased IL\u201117 and IL\u201122 levels both in the lesion and serum. Exp Dermatol 20:845\u2013847","journal-title":"Exp Dermatol"},{"key":"3800_CR59","doi-asserted-by":"crossref","first-page":"xiv","DOI":"10.1111\/j.0022-202X.2004.23488.x","volume":"123","author":"FO Nestle","year":"2004","unstructured":"Nestle FO, Conrad C (2004) The IL\u201112 family member p40 chain as a master switch and novel therapeutic target in psoriasis. J Invest Dermatol 123:xiv\u2013xv","journal-title":"J Invest Dermatol"},{"key":"3800_CR60","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N\u00a0Engl J\u00a0Med 361:496\u2013509","journal-title":"N Engl J Med"},{"key":"3800_CR61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nm0107-26","volume":"13","author":"MF Neurath","year":"2007","unstructured":"Neurath MF (2007) IL\u201123: a master regulator in Crohn disease. Nat Med 13:26\u201328","journal-title":"Nat Med"},{"key":"3800_CR62","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","volume":"13","author":"M Noack","year":"2014","unstructured":"Noack M, Miossec P (2014) Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev 13:668\u2013677","journal-title":"Autoimmun Rev"},{"key":"3800_CR63","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","volume":"43","author":"DD Patel","year":"2015","unstructured":"Patel DD, Kuchroo VK (2015) Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity 43:1040\u20131051","journal-title":"Immunity"},{"key":"3800_CR64","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/exd.12191","volume":"22","author":"J Poot","year":"2013","unstructured":"Poot J, Thewissen M, Booi D et al (2013) Characterization of skin-resident T cells using a crawl-out method and flow cytometry. Exp Dermatol 22:554\u2013555","journal-title":"Exp Dermatol"},{"key":"3800_CR65","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bcp.2012.01.001","volume":"83","author":"P Schafer","year":"2012","unstructured":"Schafer P (2012) Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol 83:1583\u20131590","journal-title":"Biochem Pharmacol"},{"key":"3800_CR66","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1074-7613(02)00393-X","volume":"17","author":"K Sch\u00e4kel","year":"2002","unstructured":"Sch\u00e4kel K, Kannagi R, Kniep B et al (2002) 6\u2011Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells. Immunity 17:289\u2013301","journal-title":"Immunity"},{"key":"3800_CR67","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4084::AID-IMMU4084>3.0.CO;2-4","volume":"28","author":"K Sch\u00e4kel","year":"1998","unstructured":"Sch\u00e4kel K, Mayer E, Federle C et al (1998) A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes. Eur J Immunol 28:4084\u20134093","journal-title":"Eur J Immunol"},{"key":"3800_CR68","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.immuni.2006.03.020","volume":"24","author":"K Sch\u00e4kel","year":"2006","unstructured":"Sch\u00e4kel K, Kietzell M Von, H\u00e4nsel A et al (2006) Human 6\u2011sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes. Immunity 24:767\u2013777","journal-title":"Immunity"},{"key":"3800_CR69","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMra041320","volume":"352","author":"MP Sch\u00f6n","year":"2005","unstructured":"Sch\u00f6n MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352:1899\u20131912","journal-title":"N Engl J Med"},{"key":"3800_CR70","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm0297-183","volume":"3","author":"MP Sch\u00f6n","year":"1997","unstructured":"Sch\u00f6n MP, Detmar M, Parker CM (1997) Murine psoriasis-like disorder induced by naive CD4+ T cells. Nat Med 3:183\u2013188","journal-title":"Nat Med"},{"key":"3800_CR71","doi-asserted-by":"crossref","first-page":"e51752","DOI":"10.1371\/journal.pone.0051752","volume":"8","author":"TP Singh","year":"2013","unstructured":"Singh TP, Sch\u00f6n MP, Wallbrecht K et al (2013) Involvement of IL\u20119 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS ONE 8:e51752","journal-title":"PLoS ONE"},{"key":"3800_CR72","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.4049\/jimmunol.0903719","volume":"184","author":"TP Singh","year":"2010","unstructured":"Singh TP, Sch\u00f6n MP, Wallbrecht K et al (2010) 8\u2011methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL\u201123\/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder. J\u00a0Immunol 184:7257\u20137267","journal-title":"J Immunol"},{"key":"3800_CR73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","volume":"13","author":"L Steinman","year":"2007","unstructured":"Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1\/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139\u2013145","journal-title":"Nat Med"},{"key":"3800_CR74","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.4049\/jimmunol.181.9.5948","volume":"181","author":"GL Stritesky","year":"2008","unstructured":"Stritesky GL, Yeh N, Kaplan MH (2008) IL\u201123 promotes maintenance but not commitment to the Th17 lineage. J Immunol 181:5948\u20135955","journal-title":"J Immunol"},{"key":"3800_CR75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ni.2797","volume":"15","author":"PR Taylor","year":"2014","unstructured":"Taylor PR, Roy S, Leal SM Jr. et al (2014) Activation of neutrophils by autocrine IL\u201117\u202fA-IL\u201117RC interactions during fungal infection is regulated by IL\u20116, IL\u201123, RORgammat and dectin-2. Nat Immunol 15:143\u2013151","journal-title":"Nat Immunol"},{"key":"3800_CR76","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","volume":"21","author":"MW Teng","year":"2015","unstructured":"Teng MW, Bowman EP, Mcelwee JJ et al (2015) IL\u201112 and IL\u201123 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat Med 21:719\u2013729","journal-title":"Nat Med"},{"key":"3800_CR77","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4049\/jimmunol.1201648","volume":"191","author":"P Tewary","year":"2013","unstructured":"Tewary P, Rosa G De La, Sharma N et al (2013) beta-Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN-alpha production by human plasmacytoid dendritic cells, and promote inflammation. J Immunol 191:865\u2013874","journal-title":"J Immunol"},{"key":"3800_CR78","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1212\/NXI.0000000000000033","volume":"1","author":"K Thomas","year":"2014","unstructured":"Thomas K, Dietze K, Wehner R et al (2014) Accumulation and therapeutic modulation of 6\u2011sulfo LacNAc(+) dendritic cells in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 1:e33","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3800_CR79","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/6.5.813","volume":"6","author":"RC Trembath","year":"1997","unstructured":"Trembath RC, Clough RL, Rosbotham JL et al (1997) Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 6:813\u2013820","journal-title":"Hum Mol Genet"},{"key":"3800_CR80","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1600-0625.2011.01376.x","volume":"20","author":"K Wallbrecht","year":"2011","unstructured":"Wallbrecht K, Drick N, Hund AC et al (2011) Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions. Exp Dermatol 20:980\u2013985","journal-title":"Exp Dermatol"},{"key":"3800_CR81","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1172\/JCI118989","volume":"98","author":"T Wrone-Smith","year":"1996","unstructured":"Wrone-Smith T, Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis. J Clin Invest 98:1878\u20131887","journal-title":"J Clin Invest"},{"key":"3800_CR82","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ddr.21271","volume":"76","author":"T Xia","year":"2015","unstructured":"Xia T, Li J, Cheng H et al (2015) Small-molecule regulators of microRNas in biomedicine. Drug Dev Res 76:375\u2013381","journal-title":"Drug Dev Res"},{"key":"3800_CR83","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/jid.2008.225","volume":"129","author":"LC Zaba","year":"2009","unstructured":"Zaba LC, Krueger JG, Lowes MA (2009) Resident and \u201cinflammatory\u201d dendritic cells in human skin. J\u00a0Invest Dermatol 129:302\u2013308","journal-title":"J Invest Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3800-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-016-3800-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3800-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T17:49:05Z","timestamp":1692380945000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-016-3800-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,31]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3800"],"URL":"https:\/\/doi.org\/10.1007\/s00105-016-3800-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,31]]}}}